drug
cipaglucosidase alfa + miglustat
Marketedupdated 5mo agoby $FOLD AMICUS THERAPEUTICS, INC.
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
News(1)
- Chutes & Ladders—Travere chief makes way for former Amicus CEOTravere Therapeutics CEO Eric Dube, Ph.D., is stepping down after overseeing the launch of the rare kidney disease drug Filspari.fiercebiotech · 7d ago
Data sources
last refreshed 3h ago
Found something off?
comments(0)
5-min edit window · permanent after that